Moreover, we show that MILIP is commonly upregulated across diverse cancer types and is critical for cancer cell survival, division and tumourigenicity, with practical implications of targeting MILIP as a therapeutic avenue for cancer treatment. This evidence concerns the gene MILIP and cancer.